TRABD2A
Basic information
Region (hg38): 2:84821650-84907008
Previous symbols: [ "C2orf89" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRABD2A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 25 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 4 | 0 |
Variants in TRABD2A
This is a list of pathogenic ClinVar variants found in the TRABD2A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-84821927-G-T | not specified | Uncertain significance (Jun 18, 2021) | ||
2-84822020-G-A | not specified | Uncertain significance (Jul 30, 2023) | ||
2-84822027-C-G | not specified | Uncertain significance (May 30, 2023) | ||
2-84822029-C-T | not specified | Likely benign (Jun 16, 2023) | ||
2-84822041-C-T | not specified | Likely benign (Jul 26, 2021) | ||
2-84822095-A-G | not specified | Uncertain significance (May 28, 2024) | ||
2-84823978-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
2-84824013-C-T | not specified | Uncertain significance (May 07, 2024) | ||
2-84824041-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
2-84824083-G-C | not specified | Uncertain significance (Jun 27, 2022) | ||
2-84832080-C-T | not specified | Uncertain significance (Nov 15, 2021) | ||
2-84832083-G-A | not specified | Uncertain significance (May 25, 2022) | ||
2-84839152-C-T | not specified | Uncertain significance (Aug 28, 2023) | ||
2-84839203-T-C | not specified | Uncertain significance (Feb 28, 2023) | ||
2-84839209-G-A | not specified | Uncertain significance (Aug 30, 2021) | ||
2-84839247-C-T | not specified | Likely benign (Dec 15, 2023) | ||
2-84839251-G-A | not specified | Uncertain significance (Jun 03, 2022) | ||
2-84839301-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
2-84870243-A-C | not specified | Uncertain significance (Dec 18, 2023) | ||
2-84870305-C-T | not specified | Uncertain significance (Oct 16, 2023) | ||
2-84870347-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
2-84870402-C-G | not specified | Uncertain significance (Feb 09, 2023) | ||
2-84870410-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
2-84870467-G-A | not specified | Uncertain significance (May 20, 2024) | ||
2-84870529-C-T | not specified | Uncertain significance (Dec 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRABD2A | protein_coding | protein_coding | ENST00000335459 | 6 | 85359 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.24e-9 | 0.260 | 124609 | 0 | 47 | 124656 | 0.000189 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.454 | 254 | 275 | 0.923 | 0.0000172 | 2917 |
Missense in Polyphen | 80 | 96.101 | 0.83246 | 1169 | ||
Synonymous | 0.359 | 104 | 109 | 0.956 | 0.00000608 | 948 |
Loss of Function | 0.661 | 15 | 18.0 | 0.832 | 0.00000103 | 194 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000680 | 0.000679 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000458 | 0.000445 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.000134 | 0.000133 |
Middle Eastern | 0.000458 | 0.000445 |
South Asian | 0.00 | 0.00 |
Other | 0.000331 | 0.000330 |
dbNSFP
Source:
- Function
- FUNCTION: Metalloprotease that acts as a negative regulator of the Wnt signaling pathway by mediating the cleavage of the 8 N- terminal residues of a subset of Wnt proteins. Following cleavage, Wnt proteins become oxidized and form large disulfide-bond oligomers, leading to their inactivation. Able to cleave WNT3A, WNT5, but not WNT11. Required for head formation. {ECO:0000269|PubMed:22726442}.;
Intolerance Scores
- loftool
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.38
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.198
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- proteolysis;Wnt signaling pathway;negative regulation of Wnt signaling pathway;positive regulation of protein oligomerization;head development;positive regulation of protein oxidation
- Cellular component
- integral component of plasma membrane;membrane;integral component of organelle membrane
- Molecular function
- endopeptidase activity;metalloendopeptidase activity;Wnt-protein binding;metal ion binding